| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.09 | 0.03 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.03 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.03 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.03 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.03 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.03 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |